DK0555446T3 - Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors - Google Patents
Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive forsInfo
- Publication number
- DK0555446T3 DK0555446T3 DK92918251T DK92918251T DK0555446T3 DK 0555446 T3 DK0555446 T3 DK 0555446T3 DK 92918251 T DK92918251 T DK 92918251T DK 92918251 T DK92918251 T DK 92918251T DK 0555446 T3 DK0555446 T3 DK 0555446T3
- Authority
- DK
- Denmark
- Prior art keywords
- antagonists
- prevention
- treatment
- partial agonists
- ht1a receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4135551A DE4135551A1 (de) | 1991-08-31 | 1991-08-31 | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
PCT/DE1992/000720 WO1993004681A1 (de) | 1991-08-31 | 1992-08-28 | VERWENDUNG VON ANTAGONISTEN ODER PARTIELLEN AGONISTEN AM 5-HT1a-REZEPTOR ZUR BEHANDLUNG UND PRÄVENTION VON KOGNITIVEN STÖRUNGEN |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0555446T3 true DK0555446T3 (da) | 2000-01-31 |
Family
ID=6443608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92918251T DK0555446T3 (da) | 1991-08-31 | 1992-08-28 | Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0555446B1 (da) |
JP (1) | JPH06501713A (da) |
AT (1) | ATE182467T1 (da) |
CA (1) | CA2093009A1 (da) |
DE (2) | DE4135551A1 (da) |
DK (1) | DK0555446T3 (da) |
ES (1) | ES2135412T3 (da) |
GR (1) | GR3031514T3 (da) |
HU (1) | HUT63331A (da) |
WO (1) | WO1993004681A1 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9223153D0 (en) * | 1992-11-05 | 1992-12-16 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
EP0710481A1 (en) * | 1994-11-02 | 1996-05-08 | Duphar International Research B.V | Use of flesinoxan for cognition enhancement |
US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
CA2327543A1 (en) | 1998-05-06 | 1999-11-11 | Duke University | Method of treating bladder and lower urinary tract syndromes |
US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
TW200800306A (en) | 2005-09-12 | 2008-01-01 | Wyeth Corp | Sustained-release formulation and uses thereof |
GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
US20130064770A1 (en) | 2010-05-28 | 2013-03-14 | Ge Healthcare Limited | Radiolabeled compounds and methods thereof |
GB201112987D0 (en) | 2011-07-28 | 2011-09-14 | Ge Healthcare Ltd | Novel compound |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2355502A1 (fr) * | 1976-06-23 | 1978-01-20 | Roussel Uclaf | Application a titre de medicaments d'un derive de la piperazine et de ses sels |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
US4897399A (en) * | 1988-04-20 | 1990-01-30 | Ciba-Geigy Corp. | Heterotertracyclic lactam derivatives, pharmaceutical compositions, and method of treating impaired memory and learning |
GB2222768B (en) * | 1988-06-17 | 1992-01-22 | Nat Res Dev | Analgesic compounds and compositions |
US4902687A (en) * | 1989-03-27 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
DE4039631A1 (de) * | 1990-12-12 | 1992-06-17 | Troponwerke Gmbh & Co Kg | Neuroprotektive kombination |
-
1991
- 1991-08-31 DE DE4135551A patent/DE4135551A1/de not_active Withdrawn
-
1992
- 1992-08-28 DK DK92918251T patent/DK0555446T3/da active
- 1992-08-28 JP JP5504830A patent/JPH06501713A/ja active Pending
- 1992-08-28 CA CA002093009A patent/CA2093009A1/en not_active Abandoned
- 1992-08-28 AT AT92918251T patent/ATE182467T1/de not_active IP Right Cessation
- 1992-08-28 ES ES92918251T patent/ES2135412T3/es not_active Expired - Lifetime
- 1992-08-28 EP EP92918251A patent/EP0555446B1/de not_active Revoked
- 1992-08-28 WO PCT/DE1992/000720 patent/WO1993004681A1/de not_active Application Discontinuation
- 1992-08-28 HU HU9301250A patent/HUT63331A/hu unknown
- 1992-08-28 DE DE59209728T patent/DE59209728D1/de not_active Revoked
-
1999
- 1999-10-13 GR GR990402609T patent/GR3031514T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUT63331A (en) | 1993-08-30 |
WO1993004681A1 (de) | 1993-03-18 |
EP0555446A1 (de) | 1993-08-18 |
GR3031514T3 (en) | 2000-01-31 |
CA2093009A1 (en) | 1993-03-01 |
ES2135412T3 (es) | 1999-11-01 |
JPH06501713A (ja) | 1994-02-24 |
DE59209728D1 (de) | 1999-09-02 |
ATE182467T1 (de) | 1999-08-15 |
DE4135551A1 (de) | 1993-03-04 |
HU9301250D0 (en) | 1993-07-28 |
EP0555446B1 (de) | 1999-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0555446T3 (da) | Anvendelse af antagonister eller partielle agonister ved 5-HT1a-receptoren til behandling og forebyggelse af kognitive fors | |
NO180538C (no) | N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene | |
ES2102367T3 (es) | Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion. | |
MX9102501A (es) | Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion. | |
DE58909463D1 (de) | Neue kondensierte heterocyclische Verbindungen und ihre Verwendung für Heilmittel. | |
MX9203187A (es) | Compuestos que inhiben lipoxigenasa que contienen indol, benzafurano y benzotiofeno. | |
DE3785684D1 (de) | Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung. | |
DK0506539T3 (da) | heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
CO4290432A1 (es) | Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos. | |
MX9102500A (es) | Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
IT7819569A0 (it) | Procedimento per la protezione di documenti dalla contraffazione, e documento cosi' ottenuto. | |
DE69510545D1 (de) | Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine | |
NO157135C (no) | Fremgangsmaate til termisk spalting av 1,2-dikloretan. | |
SE9003248D0 (sv) | Anordning foer att vaenda foeremaal, t ex i samband med avsyning av desamma | |
DK0512525T3 (da) | Carbostyrilderivater og farmaceutiske midler indeholdende disse til anvendelse som middel til forbedring af bevisthedsforstyrrelser, som stimulans for centrasnervesystemet eller som sigmareceptoragonist | |
MX9202656A (es) | Compuestos de tiadiazabiciclooctano o tiadiazabicicloocteno, procedimiento para su obtencion y composicion herbicida que los contiene. | |
DE69606777D1 (de) | Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel | |
NO883986L (no) | Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. | |
DK359887A (da) | Termohaerdnende materialer indeholdende acryl-polymere, som er praktisk taget fri for aeaktive hydrogengrupperae | |
NO910991D0 (no) | Fremgangsmaate og apparat som benyttes for omdanning av problemavfall til ufarlig aggregat. | |
DK204891D0 (da) | Hidtil ukendte cyanoalkylbenzamidderivater, fremgangsmaade til fremstilling deraf, samt anvendelse af saadanne cyanoalkylbenzamidderivater som mellemprodukt ved fremstilling af substituerede n-(imidazolinyl-methyl)-benzamider | |
DK363685D0 (da) | Katalysatorsammensaetning og anvendelse heraf til fremstilling af hydrogenholdige forbindelser | |
NO885406L (no) | Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter. | |
ES2008640T3 (es) | Derivados de aminopropanol de compuestos de 3-(3-hidroxifenil)-1-propanona, procedimiento para su fabricacion y medicamentos que contienen estos compuestos. | |
NO883987D0 (no) | Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. |